Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$56.27 - $73.77 $42,089 - $55,179
748 Added 11.97%
6,997 $483,000
Q4 2023

Jan 30, 2024

BUY
$59.06 - $75.72 $369,065 - $473,174
6,249 New
6,249 $462,000
Q1 2022

May 06, 2022

SELL
$57.56 - $82.54 $49,213 - $70,571
-855 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $61,987 - $86,081
855 New
855 $66,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.